


Navicyte Biotechnologies Revenue
Biotechnology Research • • 1-10 Employees
Navicyte Biotechnologies revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Navicyte Biotechnologies
Michael Donzanti
Chief Executive Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About Navicyte Biotechnologies
At Navicyte, we are reinventing how immune-modulating drugs are delivered to increase efficacy, safety, and flexibility for drug developers. We offer: Efficacy. Expands therapeutic index by more than 500-fold in pre-clinical models. Flexibility. Compatible with small molecules, proteins, nucleic acids, vaccines, and adjuvants. Safety. Reduces off-target exposure and lowers required therapeutic doses by up to 85%. Innovation. Tunable release kinetics and immune-targeted delivery with FDA/GMP manufacturing compatibility.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Navicyte Biotechnologies has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Navicyte Biotechnologies has never raised funding before.
Frequently asked questions
4.8
40,000 users



